Advanced Glycation End-Products Attenuate Human Mesenchymal Stem Cells and Prevent Cognate Differentiation Into Adipose Tissue, Cartilage, and Bone
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The impact of AGEs on human MSCs was studied. AGEs inhibited the proliferation of MSCs, induced apoptosis, and prevented cognate differentiation into adipose tissue, cartilage, and bone, suggesting a deleterious effect of AGEs in the pathogenesis of musculoskeletal disorders in aged and diabetic patients. Introduction: Advanced glycation end-products (AGEs) are accumulated on long-lived proteins of various tissues in advanced age and diabetes mellitus and have been implicated in chronic complication, including musculoskeletal disorders. Human mesenchymal stem cells (MSCs) potentially differentiate into mature musculoskeletal tissues during tissue repair, but the pathogenetic role of AGEs on MSCs is unclear. Materials and Methods: AGEs were prepared by incubating BSA with glucose, glyceraldehydes, or glycolaldehyde (designated as AGE-1, AGE-2, or AGE-3, respectively). Proliferation, apoptosis, and reactive oxygen species (ROS) generation were assayed in AGE-treated cells. The expression of the receptor for AGE (RAGE) was examined by immunohistochemistry and Western blotting. Involvement of RAGE-mediated signaling was examined using a neutralizing antiserum against RAGE. Differentiation into adipose tissue, cartilage, and bone were morphologically and biochemically monitored with specific markers for each. Results: AGE-2 and AGE-3, but not control nonglycated BSA and AGE-1, reduced the viable cell number and 5-bromo-2'deoxyuridine (BrdU) incorporation with increased intracellular ROS generation and the percentage of apoptotic cells. MSCs expressed RAGE and its induction was stimulated by AGE-2 and AGE-3. These AGEs inhibited adipogenic differentiation (assayed by oil red O staining, lipoprotein lipase production, and intracellular triglyceride content) and chondrogenic differentiation (assayed by safranin O staining and type II collagen production). On osteogenic differentiation, AGE-2 and AGE-3 increased alkaline phosphatase activity and intracellular calcium content; however, von Kossa staining revealed the loss of mineralization and mature bone nodule formation. The antiserum against RAGE partially prevented AGE-induced cellular events. Conclusion: AGE-2 and AGE-3 may lead to the in vivo loss of MSC mass and the delay of tissue repair by inhibiting the maturation of MSC-derived cells. The AGE-RAGE interaction may be involved in the deleterious effect of AGEs on MSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Gratzner, H. G. (1982) · Science · doi:10.1126/science.7123245 · Cited by 2,628
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,072
Age-Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow
Dr. D'Ippolito, G., Schiller, P. C., Ricordi, C., Roos, B. A., & Howard, G. A. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1115 · Cited by 906
Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapy
Bruder, S. P., Fink, D. J., & Caplan, A. I. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240560303 · Cited by 716
Yamagishi, S.-I., Edelstein, D., Du, X.-L., Kaneda, Y., Guzmán, M., & Brownlee, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007383200 · Cited by 620
Self-citationDyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535
Influence of nonenzymatic glycation on biomechanical properties of cortical bone
Vashishth, D., Gibson, G. J., Khoury, J. I., Schaffler, M. B., Kimura, J., & Fyhrie, D. P. (2001) · Bone · doi:10.1016/s8756-3282(00)00434-8 · Cited by 525
Alsalameh, S., Amin, R., Gemba, T., & Lotz, M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20269 · Cited by 523
Cited by
Stolzing, A., Jones, E., McGonagle, D., & Scutt, A. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.12.002 · Cited by 1,195
“, 2005) and diabetes (Kume et al., 2005).”
Mechanisms of diabetes mellitus-induced bone fragility
On behalf of the IOF Bone and Diabetes Working Group, Napoli, N., Chandran, M., Pierroz, D. D., Abrahamsen, B., Schwartz, A. V., & Ferrari, S. L. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.153 · Cited by 1,107
Aging of mesenchymal stem cells
SETHE, S., SCUTT, A., & STOLZING, A. (2006) · Ageing Research Reviews · doi:10.1016/j.arr.2005.10.001 · Cited by 614
Alikhani, M., Alikhani, Z., Boyd, C., MacLellan, C. M., Raptis, M., Liu, R., Pischon, N., Trackman, P. C., Gerstenfeld, L., & Graves, D. T. (2007) · Bone · doi:10.1016/j.bone.2006.09.011 · Cited by 376
Leslie, W. D., Rubin, M. R., Schwartz, A. V., & Kanis, J. A. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1759 · Cited by 352
Diabetes mellitus related bone metabolism and periodontal disease
Wu, Y.-Y., Xiao, E., & Graves, D. T. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2015.2 · Cited by 310
Immunology of Osteoporosis: A Mini-Review
Pietschmann, P., Mechtcheriakova, D., Meshcheryakova, A., Föger-Samwald, U., & Ellinger, I. (2016) · Gerontology · doi:10.1159/000431091 · Cited by 287
Characterization of bone marrow-derived mesenchymal stem cells in aging
Baker, N., Boyette, L. B., & Tuan, R. S. (2015) · Bone · doi:10.1016/j.bone.2014.10.014 · Cited by 282
Advanced glycation End-products (AGEs): an emerging concern for processed food industries
Sharma, C., Kaur, A., Thind, S. S., Singh, B., & Raina, S. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1851-y · Cited by 253
Stem cell-based bone and dental regeneration: a view of microenvironmental modulation
Zheng, C., Chen, J., Liu, S., & Jin, Y. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0060-3 · Cited by 242
“In addition, oxidative stress also contributes to BMMSC dysfunction caused by hyperglycaemia.(175) In addition, hyperglycaemia increases mitochondrial accumulation of P53, which recruits Bax and activates molecular events of apoptosis, leading to a decline of the number of BMMSCs.”
BackgroundOsteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture
Cortizo, A. M., Sedlinsky, C., McCarthy, A. D., Blanco, A., & Schurman, L. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.030 · Cited by 241
“Advanced glycation end-products have also been shown to prevent the differentiation of human mesenchymal stem cells into bone-forming osteoblasts (Kume et al., 2005).”
BackgroundAdvanced glycation end products, diabetes, and bone strength
Yamamoto, M., & Sugimoto, T. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0332-1 · Cited by 215
Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells
Cramer, C., Freisinger, E., Jones, R. K., Slakey, D. P., Dupin, C. L., Newsome, E. R., Alt, E. U., & Izadpanah, R. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0009 · Cited by 209
“Advanced glycation end (AGE) products interfere with differentiation of mesenchymal stem cells into adipogenic, chondrogenic, and osteogenic lineages [35].”
Determinants of bone strength and quality in diabetes mellitus in humans
Farr, J. N., & Khosla, S. (2016) · Bone · doi:10.1016/j.bone.2015.07.027 · Cited by 192
Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties
Picke, A.-K., Campbell, G., Napoli, N., Hofbauer, L. C., & Rauner, M. (2019) · Endocrine Connections · doi:10.1530/ec-18-0456 · Cited by 189
Effects of diabetes drugs on the skeleton
Meier, C., Schwartz, A. V., Egger, A., & Lecka-Czernik, B. (2016) · Bone · doi:10.1016/j.bone.2015.04.026 · Cited by 174
A Review of Rodent Models of Type 2 Diabetic Skeletal Fragility
Fajardo, R. J., Karim, L., Calley, V. I., & Bouxsein, M. L. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2210 · Cited by 164
The impact of type 2 diabetes on bone metabolism
Sanches, C. P., Vianna, A. G. D., & Barreto, F. D. C. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0278-1 · Cited by 115
Okazaki, K., Yamaguchi, T., Tanaka, K.-I., Notsu, M., Ogawa, N., Yano, S., & Sugimoto, T. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9641-2 · Cited by 98
“The current findings seem to accord with these previous studies [27, 39], and suggest that defects in the number of osteoblasts as well as inhibition of osteoblastic differentiation, both induced by AGEs, may underlie diabetes-related bone loss.”
InfluentialLim, M., Park, L., Shin, G., Hong, H., Kang, I., & Park, Y. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.011 · Cited by 81
RAGE Signaling in Skeletal Biology
Plotkin, L. I., Essex, A. L., & Davis, H. M. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00499-w · Cited by 54
Glucose Metabolism in Osteoblasts in Healthy and Pathophysiological Conditions
Donat, A., Knapstein, P.-R., Jiang, S., Baranowsky, A., Ballhause, T.-M., Frosch, K.-H., & Keller, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084120 · Cited by 53
Galliera, E., Marazzi, M. G., Gazzaruso, C., Gallotti, P., Coppola, A., Montalcini, T., Pujia, A., & Corsi Romanelli, M. M. (2017) · Immunity & Ageing · doi:10.1186/s12979-017-0097-0 · Cited by 18
Metadata
- Authors
- Kume, S., Kato, S., Yamagishi, S.-I., Inagaki, Y., Ueda, S., Arima, N., Okawa, T., Kojiro, M., & Nagata, K.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 20
- Issue
- 9
- Pages
- 1647-1658
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2053275761
- Cited by
- 303
- References
- 61
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.